Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2007, Vol. 27 Issue (7): 40-44    DOI:
    
Elaboration of Human Insulin Superagonism through Site-Selective Replacement at TyrB26
Download: HTML   PDF(586KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The role of conserved insulin residues TyrB26 was studied to better understand the relationship between insulin and its receptor. Insulin analogues with a single amino acid substitution or single N-methylation of the peptide bond in the position B26 were all shortened in the C-terminus of the B-chain by four amino acids. The effect of modifications was followed by the binding to the human insulin receptor. From our results: [HistidineB26]-des-tetrapeptide-(B27-B30)-insulin -B26-amide and [N-MeHisB26]-des-tetrapeptide-(B27-B30)-insulin-B26-amide had no significant effect on the binding affinity and they showed binding affinity 72 and 107 % of that of human insulin respectively; [N-MeGluB26]-des-tetrapeptide-(B27-B30)-insulin-B26-amide, [AadB26]-des- tetrapeptide-(B27-B30)-insulin-B26-amide and [Phe(4-carboxyB26)]-des-tetrapeptide-(B27-B30)– insulin-B26-amide affected the potency highly positively in vitro studies; they showed binding affinity 130, 234, 160%, respectively, of that of human insulin.



Key wordsinsulin      insulin receptor      amino acid     
Received: 07 February 2007      Published: 25 July 2007
Cite this article:

. Elaboration of Human Insulin Superagonism through Site-Selective Replacement at TyrB26. China Biotechnology, 2007, 27(7): 40-44.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2007/V27/I7/40

[1] HUANG Huan-bang,WU Yang,YANG You-hui,WANG Zhao-guan,QI Hao. Progress in Incorporation of Non-canonical Amino Acid Based on Archaeal Tyrosyl-tRNA Synthetase[J]. China Biotechnology, 2021, 41(9): 110-125.
[2] LIAO Dan-ni,ZHANG Zhao-yang,JIN Jin,LI Xia,JIA Bin. Progress in the Study of Microbial tRNA and Genetic Codon System Related Applications[J]. China Biotechnology, 2021, 41(4): 64-73.
[3] CHEN Xin-jie,QIAN Zhi-lan,LIU Qi,ZHAO Qing,ZHANG Yuan-xing,CAI Meng-hao. Modification of Aromatic Amino Acid Synthetic Pathway in Pichia pastoris to Produce Cinnamic Acid and ρ-Coumaric Acid[J]. China Biotechnology, 2021, 41(10): 52-61.
[4] Qiang-qiang PENG,Qi LIU,Ming-qiang XU,Yuan-xing ZHANG,Meng-hao CAI. Heterologous Expression of Insulin Precursor in A Newly Engineered Pichia pastoris[J]. China Biotechnology, 2019, 39(7): 48-55.
[5] Er-shu XUE,Qian-qian SONG,Kai-ren TIAN,Jian-jun QIAO,Cai-yin QINGGELE. Research Progress in the Biosynthesis and Regulation of D-amino Acids in Bacterial[J]. China Biotechnology, 2019, 39(4): 106-113.
[6] Shi-ying DANG,Yi MA,Tao WEN,Xing XIAO,An HONG. Preparation of Nanometer Composite Peptide SCM and Its Therapeutic Effect on Type II Diabetes[J]. China Biotechnology, 2018, 38(5): 17-23.
[7] LIU Cui-cui, HU Meng-die, WANG Zhi, DAI Jun, YAO Juan, LI Pei, LI Zhi-jun, CHEN Xiong, LI Xin. Metabolic Characteristics of Intracellular Trehalose Accumulation in Zygosaccharomyces rouxii[J]. China Biotechnology, 2017, 37(9): 41-47.
[8] LI Yan-wei, MA Yi, HAN Lei, XIAO Xing, DANG Shi-ying, WEN Tao, WANG De-hua, FAN Zhi-yong. A Preliminary Study on Fas Apoptosis Inhibitory Molecule FAIM 1 Inducing and Simple Obesity[J]. China Biotechnology, 2017, 37(6): 37-42.
[9] WANG De-hua, MA Yi, HAN Lei, XIAO Xing, LI Yan-wei, DANG Shi-ying, FAN Zhi-yong, WEN Tao, HONG An. Preparation of Novel Recombinant PACAP Derivative MPL-2 and Its Effect on Anti-type 2 Diabetes Mellitus[J]. China Biotechnology, 2017, 37(5): 59-65.
[10] ZHAO Shuang, LIU Liu, WU Lin-huan, MA Jun-cai. Research and Development Trend of the Technology on Corynebacterium glutamicum[J]. China Biotechnology, 2016, 36(9): 101-109.
[11] WAN Fang, CHEN Min-liang, ZHANG Bin, CHEN Jin-cong, CHEN Xue-lan. Strategy of Metabolic Engineering Microorganism for High Yield Amino Acids[J]. China Biotechnology, 2015, 35(3): 99-103.
[12] HUANG Xiang-feng, WANG Yi-han, LIU Jia-nan, LIU Jia, LU Li-jun. Research Progress in the Impacts of Promoting Factors on Biosurfactants Synthesis[J]. China Biotechnology, 2014, 34(7): 81-88.
[13] ZHAO Feng, ZHANG Yi-jun, RAN Yan-hong, WANG Xing-yong, YE Qian-jun, LI Hong-jian. Analysis of rhIL-12 Disulfide Bond And N-glycosylation Sites and C-terminal Amino Acid Sequence[J]. China Biotechnology, 2014, 34(5): 39-53.
[14] MA Yi, LUO Tian-jie, HONG An. Preparation of the Novel Recombinant VPAC2 Receptor Agonist RD and Its Molecular Mechanism of Promoteing Insulin Fuction[J]. China Biotechnology, 2014, 34(11): 60-66.
[15] LI Chuan-bao, HUA Tian, DU Hong-wu. Different Influences Between Long-term Treated IGF-Ⅰand MGF About Glycometabolism in Mice[J]. China Biotechnology, 2012, 32(04): 7-11.